Testing of Homocysteine Metabolism-Related Conditions
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLAB067 alerts
Get alerted when Policy CPCPLAB067 changes without checking for updates manually.
Monitor payer policy activity
Defines Blue Cross Blue Shield of Oklahoma reimbursement criteria for laboratory testing related to homocysteine metabolism (including newborn screening and plasma testing) and applies to providers submitting claims under BCBSOK plans.
For the diagnosis of phenotype variants of classic homocystinuria due to CBS deficiency, the pyridoxine (B6) challenge test may be reimbursable.
Code 84207 was removed from the procedure/code list.
Document updated with literature review and references revised.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.